FDA Approves Fedratinib for Myelofibrosis

Press/Media: Press / Media

PeriodAug 16 2019

Media coverage

1

Media coverage

  • TitleFDA Approves Fedratinib for Myelofibrosis
    Media name/outletOncLive
    CountryUnited States
    Date8/16/19
    PersonsRuben Mesa